Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Akkermans, Reinier P ^a   Berrevoets, Marvin A ^a   Smeele, Ivo J ^b   Lucas, Annelies E ^c   Thoonen, Bart P ^a,d   Grootens Stekelenburg, Joke G ^a   Heijdra, Yvonne F ^a   van Weel, Chris ^a   Schermer, Tjard R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b COPD and Asthma General Practitioner Advisory Group ^*  (Netherlands)

^c Diagnostiek voor U (DCE)   (Netherlands)

^d General Practice Laboratory Foundation East (SHO)   (Netherlands)

Author keywords

Airflow obstruction; Chronic obstructive pulmonary disease; Diagnosis; Lung function decline; Primary care; Spirometry

Indexed keywords

ADULT; AGE; AIRWAY OBSTRUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; SPIROMETRY; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; REFERENCE VALUE; VITAL CAPACITY;

BRONCHODILATING AGENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; VITAL CAPACITY;

EID: 84858722633     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-12     Document Type: Article

References (35)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-555. 10.1164/rccm.200703-456SO, 17507545.
2. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370(9589):741-750. 10.1016/S0140-6736(07)61377-4, 17765523.
3. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006, 27(3):627-643. 10.1183/09031936.06.00024605, 16507865.
4. National Institute for Clinical Excellence (NICE) CG101 Chronic obstructive pulmonary disease (update): NICE guideline. Date accessed: March 19, 2012, National Institute for Clinical Excellence (NICE)., http://publications.nice.org.uk/chronic-obstructive-pulmonary-disease-cg101
5. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999, 13(1):197-205. 10.1183/09031936.99.14614549, 10836348.
6. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008, 63(12):1046-1051. 10.1136/thx.2008.098483, 18786983.
7. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968. 10.1183/09031936.05.00035205, 16264058.
8. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK. The Ratio of Forced Expiratory Volume In 1-Second to Forced Vital Capacity as a Basis for Establishing Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2010, 181(5):446-451. 10.1164/rccm.200909-1366OC, 3159085, 20019341.
9. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002, 20(5):1117-1122. 10.1183/09031936.02.00023202, 12449163.
10. Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006, 130(1):200-206. 10.1378/chest.130.1.200, 16840402.
11. Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007, 30(2):232-239. 10.1183/09031936.00157906, 2516341, 17666557.
12. Vollmer WM, Gislason T, Burney P, Enright PL, Gulsvik A, Kocabas A, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009, 34(3):588-597. 10.1183/09031936.00164608, 19460786.
13. Medbo A, Melbye H. Lung function testing in the elderly-can we still use FEV1/FVC < 70% as a criterion of COPD?. Respir Med 2007, 101(6):1097-1105. 10.1016/j.rmed.2006.11.019, 17239575.
14. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80 percent of predicted and fixed thresholds misclassifies over 20% of patients. Chest 2011, 139(1):52-59. 10.1378/chest.10-0189, 20522571.
15. Hoogendoorn M, Feenstra TL, Schermer TRJ, Hesselink AE, Rutten-van Molken MPH. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Resp Med 2006, 100(1):83-86.
16. Schermer TR, Smeele IJ, Thoonen BP, Lucas AE, Grootens JG, van Boxem TJ, et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J 2008, 32(4):945-952. 10.1183/09031936.00170307, 18550607.
17. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?. Thorax 2007, 62(3):237-241. 10.1136/thx.2006.068379, 2117148, 17090573.
18. Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Anto JM, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC < 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008, 63(12):1040-1045. 10.1136/thx.2008.095554, 18492741.
19. Mannino DM, Diaz-Guzman E. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest 2012, 141(1):73-80. 10.1378/chest.11-0797, 21659434.
20. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009, 374(9691):721-732. 10.1016/S0140-6736(09)61290-3, 19716965.
21. Enright P, Brusasco V. Counterpoint: Should We Abandon FEV1/FVC < 0.70 To Detect Airway Obstruction? Yes. Chest 2010, 138(5):1040-1042. 10.1378/chest.10-2052, 21051394.
22. Celli BR, Halbert RJ. Point: Should We Abandon FEV1/FVC < 0.70 To Detect Airway Obstruction? No. Chest 2010, 138(5):1037-1040. 10.1378/chest.10-2049, 21051393.
23. Robberts B, Schermer T. Abandoning FEV 1/FVC < 0.70 to detect airway obstruction. An essential debate, but with the right emphasis?. Chest 2011, 139(5):1253-1254. 10.1378/chest.10-3099, 21540228.
24. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23(6):932-946. 10.1183/09031936.04.00014304, 15219010.
25. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
26. Falaschetti E, Laiho J, Primatesta P, Purdon S. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004, 23(3):456-463. 10.1183/09031936.04.00055204, 15065839.
27. Brandli O, Schindler C, Leuenberger PH, Baur X, Degens P, Kunzli N, et al. Re-estimated equations for 5th percentiles of lung function variables. Thorax 2000, 55(2):173-174. 1745684, 10702094.
28. Kuster SP, Kuster D, Schindler C, Rochat MK, Braun J, Held L, et al. Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years. Eur Respir J 2008, 31(4):860-868. 10.1183/09031936.00091407, 18057057.
29. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159(1):179-187.
30. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31(2):416-469. 10.1183/09031936.00099306, 18238951.
31. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest 2007, 131(2):349-355. 10.1378/chest.06-1349, 17296632.
32. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003, 22(2):268-273. 10.1183/09031936.03.00075102, 12952259.
33. Albers M, Schermer T, Heijdra Y, Molema J, Akkermans R, Van WC. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease. Thorax 2008, 63(3):201-207. 10.1136/thx.2006.068007, 17905823.
34. Garcia-Rio F, Soriano JB, Miravitlles M, Munoz L, Duran-Tauleria E, Sanchez G, et al. Subjects "over-diagnosed" as COPD by the 0.7 fixed ratio have a poor health-related quality of life. Chest 2011, 139(5):1072-1080. 10.1378/chest.10-1721, 21183609.
35. Bang KM, Gergen PJ, Kramer R, Cohen B. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993, 103(2):536-540. 10.1378/chest.103.2.536, 8432150.